Pyroptosis is a lytic form of cell death that is induced by inflammatory caspases upon activation of the canonical or noncanonical inflammasome pathways. These caspases cleave gasdermin D (GSDMD) to generate an N-terminal GSDMD fragment, which executes pyroptosis by forming membrane pores. We found that calcium influx through GSDMD pores serves as a signal for cells to initiate membrane repair by recruiting the endosomal sorting complexes required for transport (ESCRT) machinery to damaged membrane areas, such as the plasma membrane. Inhibition of the ESCRT-III machinery strongly enhances pyroptosis and interleukin-1b release in both human and murine cells after canonical or noncanonical inflammasome activation. These results not only attribute an anti-inflammatory role to membrane repair by the ESCRT-III system but also provide insight into general cellular survival mechanisms during pyroptosis.
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G asdermin D (GSDMD) is a pore-forming protein that induces pyroptosis, a necrotic form of cell death that is initiated after inflammasome activation (1) (2) (3) . The detection of pathogen-or host-derived danger signals by inflammasomes triggers the activation of inflammatory caspases (caspase-1 and -11 in mice and caspase-1 and -4 in humans), which cleave GSDMD to release autoinhibition on its N-terminal domain (GSDMD NT ) (1, 2) . The GSDMD NT targets the plasma membrane and organelles, where it forms large pores to initiate pyroptosis (4) (5) (6) (7) . Damage to the plasma membrane does not necessarily result in cell death, as it has been observed that the influx of Ca 2+ ions from the extracellular milieu triggers repair programs involving either the endocytosis of a damaged membrane or its shedding in the form of ectosomes (8) (9) (10) (11) . This latter mechanism relies on components of endosomal sorting complexes required for transport (ESCRT-0 and -III and associated factors that control ESCRT recruitment and disassembly) and has been specifically implicated in the restoration of plasma membrane integrity during necroptosis (12) or upon chemical-or laser-induced damage (10, 11) .
To this PI lo signal (Fig. 1C) . These findings confirmed that the low-level PI influx was caused by GSDMD pores and suggested that the PI lo cells had repaired their plasma membrane to prevent lysis, given the absence of a Fluo-8 signal peak.
We then used the Ca 2+ chelators BAPTA-AM and EDTA to block membrane repair, as previously reported (10, 11) . Ca 2+ chelators increased the levels of cell lysis and lactate dehydrogenase (LDH) release from WT BMDMs after LPS transfection in a dose-dependent manner ( Fig. 1D and figs. S1A and S2). Notably, Ca 2+ chelation was not cytotoxic (Fig. 1D and fig.  S2A ) and did not enhance LPS transfection or caspase-11 activation, as assessed by immunoblotting for GSDMD NT ( Fig. 1E and fig. S3A ).
BAPTA-AM also increased caspase-4-dependent pyroptosis without significantly altering GSDMD processing in HeLa cells infected with a DsifA deletion strain of Salmonella enterica serovar Typhimurium (hereafter S. typhimurium) (Fig. 1 , F and G, and fig. S3B ) (13) . Thus, Ca 2+ chelation enhanced pyroptosis in human and mouse cells, potentially by preventing the initiation of plasma membrane repair.
ESCRT proteins target membranes during membrane repair to form a punctate pattern (10, 12) . Consistently, CHMP4 puncta were observed in HeLa cells expressing CHMP4 fused to green fluorescent protein (CHMP4-GFP) from an endogenous promoter (14) after S. typhimurium infection, GSDMD NT expression, or perforin treatment (control), in contrast with untreated cells ( fig. S4 and movie S3). Moreover, Ca 2+ chelation significantly reduced the number of cells with CHMP4-GFP-positive puncta ( Fig. 2A) , indicating that ESCRT assembly requires Ca 2+ influx via GSDMD pores. Next, we transfected CHMP4-mCherry or CHMP4-GFP fusion proteins into human embryonic kidney (HEK) 293T cells stably expressing caspase-1 fused with a modified FKBP domain (DmrB-Casp-1). After dimerization and activation of DmrB-Casp-1 with B/B homodimerizer, cells underwent pyroptosis as demonstrated by morphological changes and plasma membrane annexin-V staining (Fig. 2, B and C, and movies S4 to S6). CHMP4 relocalized to a punctate pattern in DmrB-Casp-1-transgenic HEK293T cells expressing either high [ Fig. 2 Similar CHMP4 puncta were detected after activation of DmrB- Casp-11 (fig. S6A) . Although many CHMP4 puncta clearly localized to the plasma membrane (Fig. 2, B and C; figs. S4 to S6; and movie S6), puncta also formed in the cytoplasm, presumably on intracellular organelles. During necroptosis, the ESCRT machinery promotes the formation of annexin-V + plasma membrane vesicles, which have been proposed to remove damaged areas of the plasma membrane (12) . Similar annexin-V + vesicles were detected budding from HEK293T cells after activation of DmrB-Casp-1 (Fig. 2, C and D; fig. S5D ; and movie S5) or DmrB- Casp-11 (fig. S6B) . Notably, these vesicles showed clear CHMP4 puncta at the neck (Fig. 2C and figs. S5D and S6B) . When GSDMD-GFP internal ( fig. S7A ) was coexpressed, it localized close to CHMP4-mCherry puncta on the cell periphery ( fig. S7B ) and on the membrane of annexin-V + vesicles (Fig. 2D  and fig. S7C ), suggesting that ESCRT-induced ectosomes remove GSDMD pores from the plasma membrane.
We then examined the impact of ESCRT-III inactivation on inflammasome effector functions. We transiently expressed either WT or dominantnegative CHMP3 or VPS4A in immortalized mouse BMDMs (iBMDMs) or HeLa cells ( fig. S8, A to C) , because prolonged ESCRT depletion is cytotoxic (10, 12) . The expression of dominant-negative VPS4A E228Q mutant protein (Glu 228 →Gln) or the CHMP3 1-179 fragment inhibited ESCRT disassembly, as verified by a punctate pattern ( fig.  S8D ), and reduced cell viability after 20 to 24 hours of expression ( fig. S8E ). This prompted us to restrict our experiments to a maximum of 15 hours postinduction with doxycycline (Dox). The expression of VPS4A E228Q in WT iBMDMs resulted in two-to fourfold-higher levels of cell death after LPS transfection compared with VPS4A WT -expressing controls (Fig. 3, A and B ; fig. S9 ; and movies S7 and S8) and also decreased recovery after LPS transfection ( fig. S10 ). ESCRT inactivation also strongly enhanced interleukin1b (IL-1b) release after LPS transfection (Fig. 3C ), but notably, it enhanced neither LDH nor cytokine release from untreated, Casp11 −/− , or Gsdmd −/− cells ( fig. S11 ). IL-1b release after noncanonical inflammasome activation depends on GSDMD-induced K + efflux and subsequent activation of the NLRP3-caspase-1 pathway (15, 16) . Because LPS-transfected WT iBMDMs expressing VPS4A E228Q had higher levels of processed, activated caspase-1 and released more mature IL-1b than VPS4A WT -expressing control cells (Fig. 3, C  and D) , we hypothesized that this was due to enhanced K + efflux via increased GSDMD pore Rühl NT, nontargeting siRNA. Graphs show means ± SD. **P < 0.01; ***P < 0.001, ****P < 0.0001; ns, not significant (Student's t test). Results are representative of at least three independent experiments. VPS4A WT/E228Q expression in panels (A) to (F) was induced with 0.5 mg/ml of Dox for 6 hours.
formation. Consistently, and in agreement with previous reports (15), cytokine release but not cell death was attenuated by treatment with the NLRP3 inhibitor MCC950 or high extracellular K + (Fig. 3E and fig. S12A ). We next assayed GSDMD processing and found that GSDMD NT levels were slightly enhanced in VPS4A E228Q -transgenic iBMDMs compared with VPS4A WT -transgenic iBMDMs at high LPS concentrations (Fig. 3F) . We postulated that the enhanced GSDMD processing was caused by enhanced NLRP3 inflammasome activation (Fig.  3E and fig. S12A ) and was thus caspase-1 dependent. Indeed, GSDMD processing did not differ between VPS4A E228Q -and VPS4A WT -expressing iBMDMs in the presence of MCC950 (Fig. 3F and  fig. S12B ), confirming that ESCRT negatively regulates pyroptosis downstream of caspase-11 activation and GSDMD processing.
To study the role of ESCRT-associated proteins, we knocked down the expression of ESCRT-I and -III proteins and of two proteins, ALG2 and ALIX, that have been implicated in the Ca 2+ -dependent recruitment of ESCRTs (8) . As spontaneous necroptosis occurs upon ESCRT depletion (12), we performed all knockdown experiments in Ripk3 −/− iBMDMs (12), which remained viable despite successful protein depletion ( fig. S13, A to E) . The knockdown of CHMP3, VPS4A, and VPS4B significantly enhanced pyroptosis and IL-1b release in Ripk3 −/− iBMDMs transfected with LPS (Fig.  3G) . By contrast, single or double knockdown of ALIX and ALG2 had no impact on pyroptosis (Fig. 3G ). ALG2 and ALIX may act redundantly with TSG101 (17), but simultaneous depletion was not possible due to the cytotoxicity of TSG101 depletion in BMDMs ( fig. S13F ).
ESCRT inactivation also enhanced pyroptosis in human cells infected with DsifA S. typhimurium ( fig. S14, A to D) . In this experiment, ESCRTs appeared to have an additional function upstream of inflammasomes, as ESCRT inactivation resulted in higher levels of ruptured, galectin-3 + Salmonellacontaining vacuoles ( fig. S15 , A to C), despite equal levels of bacterial invasion (fig. S14, E and F). This implied that ESCRTs repair damaged vacuoles and endosomes, as suggested recently (17) , and thereby control bacterial escape into the cytosol. However, the elevated levels of cytosolic bacteria in ESCRT-depleted cells showed only a negligible impact on GSDMD processing at the time points examined ( fig. S15, D to F) .
We next asked if ESCRTs also regulate cell death after canonical inflammasome activation. Ca 2+ chelation significantly enhanced pyroptosis after DNA transfection of BMDMs (fig. S16, A and B), without changing caspase-1 processing ( fig. S16, C and D) . Furthermore, ESCRT depletion significantly enhanced cell death and IL-1b release in iBMDMs after NLRC4 activation with logphase S. typhimurium bacteria but did not enhance ASC speck formation or processing of caspase-1 or GSDMD (Fig. 4, A and B, and fig. S17 ). This indicated that ESCRTs restrict pyroptosis downstream of GSDMD. To further exclude any effects of ESCRT depletion on the upstream signals that control caspase-1 activation, we used DmrB-Casp-1-transgenic HEK293T cells. Activation of DmrB-Casp-1 induced pyroptosis with faster kinetics in cells expressing dominantnegative VPS4A E228Q or CHMP3 1-179 than in cells expressing the WT proteins, particularly if DmrBCasp-1 activity was limited by adding an inhibitory washout compound (Fig. 4C and fig. S18A ). B/B homodimerizer enhanced pyroptosis in ESCRT-deficient cells compared with ESCRTproficient cells across a variety of concentrations ( Fig. 4D and fig. S18B ). Notably, ESCRT inactivation did not affect GSDMD processing (Fig. 4E  and fig. S18C ) and enhanced pyroptosis only in DmrB-Casp-1-transgenic HEK293T cells when Rühl Immunoblots show equal expression levels of VPS4A proteins. (E) GSDMD processing at t = 60 min of DmrB-Casp-1-transgenic HEK293T cells treated as described for panel (C) except 50 nM B/B HD was used. (F) LDH and IL-1b release at t = 90 min from DmrB-Casp-1-transgenic and proIL-1b doubletransgenic HEK293T cells expressing FLAG-hGSDMD-V5 and Dox-inducible VPS4A constructs. Cells were treated with B/B HD at t = 0 and with a 50-fold excess of washout compound at t = 30 min. Graphs show means ± SD. *P < 0.05; **P < 0.01; ***P < 0.001, ****P < 0. GSDMD was coexpressed (fig. S18, D and E) . Finally, ESCRT inactivation also enhanced IL-1b release, as shown in pro-IL-1b-transgenic HEK293T cells (Fig. 4F and fig. S18F ).
Thus, in a variety of cell lines and systems, the ESCRT machinery dampens GSDMD poremediated cell death and negatively regulates IL-1b secretion after canonical or noncanonical inflammasome activation. We propose that ESCRTs play a central role in removing GSDMD pores from the plasma membrane in the form of ectosomes and that membrane repair could allow cells to restrict pyroptosis while permitting limited GSDMD-dependent cytokine release (18, 19) . Our results place ESCRTs downstream of caspase activation and GSDMD processing, but they do not exclude the possibility that ESCRTs also control the activation of inflammasomes (e.g., by repairing damaged bacteria-containing vacuoles and thus restricting cytosolic access of bacteriaderived ligands). Further experiments are needed to assess this aspect of ESCRTs and to determine if ESCRT-induced vesicles transport cytokines and danger signals.
